Which of the following is the primary biochemical consequence of thiamine deficiency in relation to energy metabolism?
What is the biochemical mechanism by which cyanide inhibits cellular respiration?
Which molecule serves as the final electron acceptor in the electron transport chain?
During a prolonged fast, which enzyme is essential for maintaining blood glucose levels through gluconeogenesis in the liver?
A patient exhibits symptoms of lactic acidosis and hyperlipidemia. Genetic testing reveals a mutation in the enzyme pyruvate dehydrogenase complex. Which metabolic process is directly affected?
In a patient with severe anemia, which enzyme's activity is most likely to be affected?
Which of the following enzymes catalyzes the conversion of succinate to fumarate in the TCA cycle?
What is the effect of uncoupling proteins on ATP synthesis in the mitochondrial electron transport chain?
What is one of the functions of the mitochondrial enzyme complex pyruvate dehydrogenase?
Succinate thiokinase catalyzes the production of:
Explanation: ***Correct: Impaired acetyl-CoA formation*** - **Thiamine pyrophosphate (TPP)** is an essential coenzyme for the **pyruvate dehydrogenase complex**, which catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA. - In thiamine deficiency, this enzyme complex cannot function properly, resulting in **impaired acetyl-CoA formation** - this is the **primary and direct biochemical consequence**. - This represents the fundamental enzymatic defect from which all other metabolic disturbances arise. - Impaired acetyl-CoA formation affects both **energy production** (reduced entry into TCA cycle) and **biosynthetic pathways**. *Incorrect: Increased pyruvate accumulation* - While pyruvate accumulation does occur in thiamine deficiency, it is a **secondary consequence** of impaired acetyl-CoA formation, not the primary defect. - Pyruvate builds up because it cannot be efficiently converted to acetyl-CoA, leading to shunting toward **lactate** (causing lactic acidosis). - This is an **observable metabolic result** rather than the primary biochemical consequence. *Incorrect: Decreased TCA cycle activity* - TCA cycle activity is reduced in thiamine deficiency due to both **reduced acetyl-CoA entry** and impaired **α-ketoglutarate dehydrogenase** (another TPP-dependent enzyme). - However, this is a **downstream effect** occurring after the primary defect in acetyl-CoA formation. - The question asks for the primary consequence in relation to energy metabolism. *Incorrect: Reduced fatty acid synthesis* - Fatty acid synthesis requires acetyl-CoA as a substrate and NADPH as a reducing agent. - While both are affected by thiamine deficiency (reduced acetyl-CoA production and impaired **transketolase** affecting NADPH via pentose phosphate pathway), this is a **tertiary/indirect effect**. - This is not the primary biochemical consequence of thiamine deficiency in energy metabolism.
Explanation: ***Inhibition of Complex IV in the electron transport chain*** - **Cyanide** acts as a potent poison by binding irreversibly to the **ferric iron (Fe3+)** in the heme a3 component of **cytochrome c oxidase (Complex IV)**. - This binding prevents the transfer of electrons to oxygen, thereby arresting the entire **electron transport chain** and halting ATP production. *Uncoupling of oxidative phosphorylation* - **Uncoupling agents** (e.g., dinitrophenol) dissipate the proton gradient across the inner mitochondrial membrane, allowing electron transport to continue without ATP synthesis. - While this also reduces ATP, it is a different mechanism from cyanide's direct inhibition of electron flow. *Blockage of ATP synthase* - **ATP synthase (Complex V)** is responsible for synthesizing ATP using the proton gradient generated by the electron transport chain. - Inhibitors like **oligomycin** block this enzyme, preventing ATP production but not directly stopping electron transport. *Reduction of NADH production* - **NADH production** occurs during glycolysis and the citric acid cycle, upstream of the electron transport chain. - Cyanide does not directly interfere with these metabolic pathways; its primary action is at the terminal oxidation step.
Explanation: **Oxygen** - **Oxygen** possesses a high **electronegativity** and readily accepts electrons at the end of the **electron transport chain**, forming water. - This acceptance of electrons is crucial for creating the **proton gradient** that drives ATP synthesis. *Carbon dioxide* - **Carbon dioxide** is a waste product of cellular respiration, specifically from the **Krebs cycle**, and is expelled from the body. - It does not function as an electron acceptor in the electron transport chain; rather, it's a byproduct of **oxidative metabolism**. *NAD+* - **NAD+** (nicotinamide adenine dinucleotide) is a coenzyme that acts as an **electron carrier**, accepting electrons from metabolic reactions and carrying them to the electron transport chain. - It is an electron acceptor at earlier stages of cellular respiration (e.g., glycolysis, Krebs cycle), but not the final one. *ATP* - **ATP** (adenosine triphosphate) is the primary **energy currency** of the cell, produced by the electron transport chain, not an electron acceptor. - Its formation is the ultimate goal of the electron transport chain via **oxidative phosphorylation**.
Explanation: ***Pyruvate carboxylase*** - This enzyme catalyzes the conversion of **pyruvate to oxaloacetate**, a crucial first step in **gluconeogenesis** in the liver. - During a prolonged fast, **pyruvate carboxylase** is essential for utilizing non-carbohydrate precursors like amino acids to synthesize new glucose. *Hexokinase* - **Hexokinase** phosphorylates glucose to **glucose-6-phosphate**, trapping glucose within the cell for glycolysis or glycogen synthesis. - Its activity would **lower blood glucose** by consuming it, which is contrary to the goal of maintaining blood glucose during a fast. *Phosphofructokinase* - **Phosphofructokinase-1 (PFK-1)** is a key regulatory enzyme in **glycolysis**, catalyzing the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. - Its activation promotes **glucose breakdown**, which counteracts the need for new glucose production during a fast. *Lactate dehydrogenase* - **Lactate dehydrogenase** interconverts **pyruvate and lactate**, allowing for regeneration of NAD+ during anaerobic conditions. - While lactate can be a gluconeogenic precursor, **lactate dehydrogenase** itself does not initiate the main gluconeogenic pathway; it primarily facilitates the anaerobic metabolism of glucose.
Explanation: ***Citric acid cycle*** - The **pyruvate dehydrogenase complex (PDC)** catalyzes the irreversible conversion of **pyruvate to acetyl-CoA**, which is the essential substrate that enters the citric acid cycle. - This reaction is the **critical link between glycolysis and the citric acid cycle**, and its impairment directly reduces the availability of acetyl-CoA for oxidative metabolism. - A mutation in PDC leads to pyruvate accumulation, which is then converted to **lactate** (causing **lactic acidosis**), and reduces acetyl-CoA production for the citric acid cycle, impairing **energy generation** and promoting **hyperlipidemia** due to impaired fatty acid synthesis regulation. *Glycolysis* - Glycolysis converts **glucose into pyruvate** and remains functionally intact in PDC deficiency. - A defect in PDC causes pyruvate to *accumulate* rather than being converted to acetyl-CoA, but does not directly impair the glycolytic pathway itself. - The lactic acidosis occurs *downstream* of glycolysis due to pyruvate buildup. *Gluconeogenesis* - Gluconeogenesis synthesizes glucose from non-carbohydrate precursors (lactate, amino acids, glycerol) primarily in liver and kidney. - While PDC deficiency affects carbohydrate metabolism broadly, gluconeogenesis itself is not the primary process directly impacted by loss of pyruvate-to-acetyl-CoA conversion. - PDC deficiency typically does not present with hypoglycemia as the primary feature. *Fatty acid oxidation* - Fatty acid oxidation (β-oxidation) breaks down fatty acids to produce acetyl-CoA independently of PDC. - PDC deficiency affects acetyl-CoA production *from carbohydrate sources*, not from fatty acid breakdown. - The hyperlipidemia results from impaired lipid metabolism and energy dysregulation, not from defective fatty acid oxidation itself.
Explanation: ***Cytochrome c oxidase*** - **Cytochrome c oxidase** (Complex IV) is a crucial enzyme in the **electron transport chain**, requiring oxygen as the final electron acceptor to produce ATP. - In **severe anemia**, reduced hemoglobin levels lead to decreased oxygen-carrying capacity, directly limiting the availability of oxygen needed for cytochrome c oxidase activity and thus impairing **oxidative phosphorylation**. *Catalase* - **Catalase** primarily functions to detoxify **hydrogen peroxide** into water and oxygen, a process less directly affected by systemic oxygen levels. - Its activity is more critical in protecting cells from **oxidative stress** rather than directly mediating oxygen-dependent energy production. *Peroxisomal oxidase* - **Peroxisomal oxidases** are involved in various metabolic reactions, including **fatty acid beta-oxidation** and detoxification, producing hydrogen peroxide. - While they use oxygen, their role is not as central to immediate energy production and their activity is less sensitive to the acute oxygen deficiency seen in severe anemia compared to the electron transport chain. *Glucose-6-phosphate dehydrogenase* - **Glucose-6-phosphate dehydrogenase (G6PD)** is the rate-limiting enzyme in the **pentose phosphate pathway**, producing NADPH. - NADPH is essential for maintaining **reduced glutathione** and protecting red blood cells from oxidative damage, but G6PD activity is not directly dependent on oxygen availability for its primary function.
Explanation: ***Succinate dehydrogenase*** - This enzyme catalyzes the **dehydrogenation of succinate to fumarate** in the **TCA cycle**, transferring electrons to FAD. - It's unique as it is the only enzyme of the TCA cycle that is directly embedded in the **inner mitochondrial membrane** and participates in the electron transport chain (as complex II). *Citrate synthase* - This enzyme catalyzes the first step of the TCA cycle, the condensation of **acetyl-CoA with oxaloacetate** to form **citrate**. - It is not involved in the conversion of succinate to fumarate. *Aconitase* - This enzyme isomerizes **citrate to isocitrate** through an intermediate of cis-aconitate. - Its role is upstream of succinate in the TCA cycle. *Isocitrate dehydrogenase* - This enzyme catalyzes the oxidative decarboxylation of **isocitrate to α-ketoglutarate**, producing the first CO2 and NADH of the TCA cycle. - It functions earlier in the cycle, prior to the formation of succinate.
Explanation: ***Uncoupling proteins decrease ATP synthesis*** - Uncoupling proteins (UCPs) create a **proton leak** across the inner mitochondrial membrane, dissipating the **proton gradient** without passing through ATP synthase. - This dissipation of the **chemiosmotic gradient** directly reduces the driving force for **ATP synthesis**. *Uncoupling proteins increase ATP synthesis* - This is incorrect because UCPs provide an alternative pathway for protons to return to the mitochondrial matrix, bypassing **ATP synthase**. - By short-circuiting the proton flow, they reduce the efficiency of **oxidative phosphorylation**, leading to less ATP production. *Uncoupling proteins decrease the electron transport rate* - This is incorrect; in fact, uncoupling can actually **increase the electron transport rate**. - When the proton gradient is dissipated by UCPs, the **electron transport chain** is less inhibited by the buildup of back-pressure from the high proton concentration, thus allowing electrons to flow faster. *Uncoupling proteins increase the proton gradient* - This is incorrect. Uncoupling proteins **reduce the proton gradient** by allowing protons to re-enter the mitochondrial matrix without passing through **ATP synthase**. - They act as **proton channels**, effectively "uncoupling" the electron transport from **ATP production**.
Explanation: ***Converts pyruvate to acetyl-CoA, a key step in aerobic metabolism.*** - The **pyruvate dehydrogenase complex (PDH)** is located in the **mitochondrial matrix** and catalyzes the **oxidative decarboxylation of pyruvate**. - This reaction forms **acetyl-CoA**, which then enters the **citric acid cycle (Krebs cycle)** for further energy production. *Catalyzes the conversion of glucose to pyruvate* - This process is known as **glycolysis**, which occurs in the **cytoplasm**. - **Pyruvate dehydrogenase** does not participate in glycolysis; its role begins after pyruvate is formed. *Breaks down fatty acids to form acetyl-CoA* - The breakdown of fatty acids to acetyl-CoA is called **beta-oxidation**, which occurs in the **mitochondrial matrix**. - While both processes produce acetyl-CoA, they involve different enzymatic pathways; **PDH** is specific to pyruvate conversion. *Synthesizes ATP from ADP and inorganic phosphate* - The primary enzymes responsible for ATP synthesis are involved in **oxidative phosphorylation** (e.g., **ATP synthase**) and **substrate-level phosphorylation**. - Pyruvate dehydrogenase is involved in preparing substrates for energy generation, not directly synthesizing ATP.
Explanation: ***GTP*** - **Succinate thiokinase** (also known as **succinyl-CoA synthetase**) is an enzyme in the **Krebs cycle (TCA cycle)** that catalyzes the substrate-level phosphorylation of **GDP to GTP** in most mammalian tissues. - This reaction involves the cleavage of the **thioester bond** in succinyl-CoA, releasing energy used for **GTP synthesis**. - The reaction: Succinyl-CoA + GDP + Pi → Succinate + GTP + CoA *ATP* - While some isoforms of succinyl-CoA synthetase can produce **ATP** from ADP (particularly in muscle and brain tissues), the primary product in most mammalian tissues is **GTP**. - GTP can be readily converted to ATP by **nucleoside diphosphate kinase**, making them energetically equivalent. - However, GTP is the characteristic product of this enzyme in the TCA cycle. *NADH* - **NADH** is produced by other dehydrogenase enzymes in the Krebs cycle: **isocitrate dehydrogenase**, **alpha-ketoglutarate dehydrogenase**, and **malate dehydrogenase**. - NADH is a high-energy electron carrier used in the **electron transport chain**, not a product of succinate thiokinase. *FADH2* - **FADH2** is produced by **succinate dehydrogenase** (Complex II), which catalyzes the conversion of succinate to fumarate in the next step of the Krebs cycle. - This is a different enzyme and a different electron carrier, distinct from the nucleotide triphosphate produced by succinate thiokinase.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free